Besides writing, she enjoys hiking, traveling, yoga, and cooking healthy meals with her family
The Therapeutic Goods Administration's (TGA) warning covers the following glucagon-like peptide-1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and obesity: Semaglutide, sold as Ozempic, Wegovy Tirzepatide, sold as Mounjaro Dulaglutide, sold as Trulicity Liraglutide, sold as Saxenda The TGA said the products had the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy (NAION)
Solutions such as platforms like MeAgain centralize injection scheduling, match medication peaks to reported cravings, and offer food, protein, and hydration goals alongside injection-site logging, giving clinicians and patients a single source of truth that reduces missed doses and clarifies progress
By adhering to this carefully planned chart and consulting regularly with healthcare providers, patients are better equipped to maximize the benefits of compounded Semaglutide while mitigating potential risks